A new determinant of H5N1 influenza virus pathogenesis in mammals

Journal of Virology

Volumn 87, Issue 9, 2013, Pages 4795-4796

  Dermody, Terence S ^a   Sandri Goldin, Rozanne M ^b   Shenk, Thomas ^c  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c PRINCETON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VIRUS HEMAGGLUTININ;

BIOSAFETY; EDITORIAL; HOST RANGE; INFLUENZA A (H5N1); NONHUMAN; PEER REVIEW; PH; PRIORITY JOURNAL; PUBLICATION; VIRUS MUTATION; VIRUS PATHOGENESIS; VIRUS REPLICATION; VIRUS STRAIN; VIRUS TRANSMISSION; VIRUS VIRULENCE;

ANIMALS; FEMALE; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA IN BIRDS; VIRUS REPLICATION;

MAMMALIA; ORTHOMYXOVIRIDAE;

EID: 84876320288     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00474-13     Document Type: Editorial

References (5)

1. Zaraket H, Bridges OA, Russell CJ. 2013. The pH of activation of the hemagglutinin protein regulates H5N1 influenza virus replication and pathogenesis in mice. J. Virol. 87:4826-4834.
2. Imai M, Watanabe T, Hatta M, Das SC, Ozawa M, Shinya K, Zhong G, Hanson A, Katsura H, Watanabe S, Li C, Kawakami E, Yamada S, Kiso M, Suzuki Y, Maher EA, Neumann G, Kawaoka Y. 2012. Experimental adaptation of an influenza H5 HA confers respiratory droplet transmission to a reassortant H5 HA/H1N1 virus in ferrets. Nature 486:420-428.
3. Ilyushina NA, Govorkova EA, Russell CJ, Hoffmann E, Webster RG. 2007. Contribution of H7 haemagglutinin to amantadine resistance and infectivity of influenza virus. J. Gen. Virol. 88:1266-1274.
4. Keleta L, Ibricevic A, Bovin NV, Brody SL, Brown EG. 2008. Experimental evolution of human influenza virusH3hemagglutinin in the mouse lung identifies adaptive regions in HA1 and HA2. J. Virol. 82:11599-11608.
5. National Science Advisory Board for Biosecurity. 2012. The United States Government policy for oversight of life sciences dual use research of concern. Office of Biotechnology Activities, National Institutes of Health, Bethesda, MD. http://oba.od.nih.gov/oba/biosecurity/pdf/united_states_government_policy_for_oversight_of_durc_final_version_032812.pdf. Accessed 10 February 2013.